Hosted on MSN2d
BMS’ Phase II trial of CAR T cell therapy meets primary endpoint
Bristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...
GH Research announces primary endpoint met in Phase 2b trial of GH001
PLC reported the primary endpoint was met in a randomized, double-blind, placebo-controlled Phase 2b clinical trial with ...
Hosted on MSN1mon
GSK’s combo therapy trial for advanced ovarian cancer meets primary endpoint
GSK has reported that the double-blind, randomised Phase III FIRST-ENGOT-OV44 trial of Zejula (niraparib) and Jemperli (dostarlimab) combination in treating first-line advanced ovarian cancer met ...
Nasdaq1mon
Axsome falls after one of two Alzheimer’s trials misses primary endpoint
Axsome Therapeutics (AXSM) announced this morning that while the ACCORD-2 Phase 3 trial achieved the primary endpoint with AXS-05 statistically delayed the time to relapse of agitation in patients ...